サンプル依頼リスト カート
  • English
  • Korean
表紙：ネットワークPOCグルコース検査装置の世界市場規模調査＆予測：タイプ別（0.5uL、1uL、5uL、その他）、用途別（病院、診療所、家庭）、地域別分析、2023-2030年
市場調査レポート
商品コード
1303567

ネットワークPOCグルコース検査装置の世界市場規模調査＆予測：タイプ別（0.5uL、1uL、5uL、その他）、用途別（病院、診療所、家庭）、地域別分析、2023-2030年

Global Network Point-of-Care Glucose Testing Device Market Size study & Forecast, by Type (0.5uL, 1uL, 5uL, Others), By Application (Hospital, Clinic, Household) and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ネットワークPOCグルコース検査装置の世界市場規模調査＆予測：タイプ別（0.5uL、1uL、5uL、その他）、用途別（病院、診療所、家庭）、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ネットワークPOCグルコース検査装置は、病院、診療所、医院などのポイントオブケアでリアルタイムに血糖値を測定するために使用される医療機器です。

この装置はネットワークに接続され、データの転送や共有が可能で、糖尿病患者の遠隔モニタリングや管理ができます。糖尿病患者の増加や医療用検査キットの需要拡大などの要因により、ネットワークPOCグルコース検査装置市場は拡大しています。ネットワークPOCグルコース検査装置は、リアルタイムのグルコースモニタリング、データ共有、遠隔管理を可能にすることで、糖尿病を管理する効率的で効果的な手段を提供し、患者の転帰とケアの質の向上につながります。糖尿病の有病率は、ここ数十年の間に徐々に増加しています。

世界保健機関（WHO）によると、糖尿病は2021年に世界で5億3,700万人の成人に影響を及ぼし、10人に1人がその他の糖尿病を経験しています。さらに、国際糖尿病連合によれば、その総数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。糖尿病と診断されていない成人の割合は44.7％と推定され、その81％以上が中低所得国に住んでいます。糖尿病は、2021年の世界保健支出に推定9,660億米ドルをもたらしました。スペースを牽引するもう一つの主要な要素は、医療用検査キットの需要拡大です。Statistaによると、医療機器の売上高は2021年に4,809億7,000万米ドルに達しました。医療機器からの収益は今後さらに伸び、2024年には5,708億米ドルに達すると予測されています。また、2021年には、EUのヘルスケア組織の42％が疾病識別にAI技術を採用しており、さらに19％が今後3年以内に実施する意向を示しています。また、患者データを取り込む需要の増加や、糖尿病診断に対する政府のイニシアチブの高まりは、予測期間中に市場に有利な成長見通しを生み出すと思われます。しかし、ネットワークPOCグルコース検査装置のコストが高いため、2023年から2030年の予測期間を通じて市場の成長が抑制されます。

ネットワークPOCグルコース検査装置の世界市場調査において考慮した主要地域は以下の通りです：アジア太平洋、北米、欧州、ラテンアメリカ、中東＆アフリカ。北米は2022年に市場を独占したが、これは同地域の疾患有病率が上昇しているためです。さらに、アジア太平洋地域は、予測期間中に大きく成長することが期待されています。これは、高齢者やターゲット人口統計の増加、主要市場参入企業の地域成長などの要因によるものです。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • ネットワークPOCグルコース検査装置市場：地域別、2020-2030年
    • ネットワークPOCグルコース検査装置市場：タイプ別、2020-2030年
    • ネットワークPOCグルコース検査装置市場：アプリケーション別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 ネットワークPOCグルコース検査装置の世界市場定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 ネットワークPOCグルコース検査装置の世界市場力学

  • ネットワークPOCグルコース検査装置市場インパクト分析（2020-2030年）
    • 市場促進要因
      • 糖尿病患者の増加
      • 医療用検査キットの需要拡大
    • 市場の課題
      • ネットワークPOCグルコース検査装置の高コスト
    • 市場機会
      • 患者データを取り込む需要の増加
      • 糖尿病診断に対する政府のイニシアティブの高まり

第4章 世界のネットワークPOCグルコース検査装置市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 ネットワークPOCグルコース検査装置の世界市場：タイプ別

  • 市場スナップショット
  • ネットワークPOCグルコース検査装置の世界市場：タイプ別、実績 - ポテンシャル分析
  • ネットワークPOCグルコース検査装置の世界市場：タイプ別2020-2030年推定・予測
  • ネットワークPOCグルコース検査装置市場、サブセグメント別分析
    • 0.5uL
    • 1uL
    • 5uL
    • その他

第6章 ネットワークPOCグルコース検査装置の世界市場：用途別

  • 市場スナップショット
  • ネットワークPOCグルコース検査装置の世界市場：用途別、実績- 潜在能力分析
  • ネットワークPOCグルコース検査装置の世界市場：用途別推定・予測2020-2030年
  • ネットワークPOCグルコース検査装置市場、サブセグメント別分析
    • 病院
    • クリニック
    • 家庭用

第7章 ネットワークPOCグルコース検査装置の世界市場：地域別分析

  • 主要国
  • 主要新興国
  • ネットワークPOCグルコース検査装置市場：地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • アプリケーションの推定・予測、2020-2030年
    • カナダ
  • 欧州ネットワークPOCグルコース検査装置市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のネットワークPOCグルコース検査装置市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのネットワークPOCグルコース検査装置市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Danaher Corporation
    • Abbott Laboratories
    • Nipro India Corporation Pvt Ltd.
    • Nova Biomedical
    • ACON Laboratories, Inc.
    • Trividia Health, Inc.
    • Prodigy Diabetes Care, LLC
    • Bayer AG/Ascensia Diabetes Care Holdings AG
    • EKF Diagnostics

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Network Point-of-Care Glucose Testing Device Market, report scope
  • TABLE 2. Global Network Point-of-Care Glucose Testing Device Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Network Point-of-Care Glucose Testing Device Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Network Point-of-Care Glucose Testing Device Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Network Point-of-Care Glucose Testing Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Network Point-of-Care Glucose Testing Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Network Point-of-Care Glucose Testing Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Network Point-of-Care Glucose Testing Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Network Point-of-Care Glucose Testing Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Network Point-of-Care Glucose Testing Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Network Point-of-Care Glucose Testing Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Network Point-of-Care Glucose Testing Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Network Point-of-Care Glucose Testing Device Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Network Point-of-Care Glucose Testing Device Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Network Point-of-Care Glucose Testing Device Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Network Point-of-Care Glucose Testing Device Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Network Point-of-Care Glucose Testing Device Market
  • TABLE 70. List of primary sources, used in the study of global Network Point-of-Care Glucose Testing Device Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Network Point-of-Care Glucose Testing Device Market, research methodology
  • FIG 2. Global Network Point-of-Care Glucose Testing Device Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Network Point-of-Care Glucose Testing Device Market, key trends 2022
  • FIG 5. Global Network Point-of-Care Glucose Testing Device Market, growth prospects 2023-2030
  • FIG 6. Global Network Point-of-Care Glucose Testing Device Market, porters 5 force model
  • FIG 7. Global Network Point-of-Care Glucose Testing Device Market, pest analysis
  • FIG 8. Global Network Point-of-Care Glucose Testing Device Market, value chain analysis
  • FIG 9. Global Network Point-of-Care Glucose Testing Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Network Point-of-Care Glucose Testing Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Network Point-of-Care Glucose Testing Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Network Point-of-Care Glucose Testing Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Network Point-of-Care Glucose Testing Device Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Network Point-of-Care Glucose Testing Device Market, regional snapshot 2020 & 2030
  • FIG 15. North America Network Point-of-Care Glucose Testing Device Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Network Point-of-Care Glucose Testing Device Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Network Point-of-Care Glucose Testing Device Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Network Point-of-Care Glucose Testing Device Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Network Point-of-Care Glucose Testing Device Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Network Point-of-Care Glucose Testing Device Market is valued at approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx% over the forecast period 2023-2030. A network point-of-care glucose testing device is a medical device used to measure blood glucose levels in real-time at the point of care, such as a hospital, clinic, or doctor's office. This device is connected to a network, which allows for data transfer and sharing, enabling remote monitoring and management of patients with diabetes. The Network Point-of-Care Glucose Testing Device market is expanding because of factors such as increasing cases of diabetes and growing demand for medical testing kits. Network point-of-care glucose testing devices can provide an efficient and effective means of managing diabetes by allowing for real-time glucose monitoring, data sharing, and remote management, leading to improved patient outcomes and quality of care. Its prevalence has progressively increased during the last few decades.

According to the World Health Organization, diabetes affected 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, as per the International Diabetes Federation, the total number is predicted to rise to 643 million by 2030 and to 783 million by 2045. An estimated 44.7% of adults living with diabetes are undiagnosed and over 81% of these people live in low- and middle-income countries. Diabetes was responsible for an estimated USD 966 billion in global health expenditure in 2021. Another major component driving space is growing demand for medical testing kits. According to Statista, the sales of medical devices generated revenue of USD 480.97 billion in 2021. Revenue from medical devices was forecast to grow even further in the following years, reaching USD 570.80 billion by 2024. In addition, in 2021, 42 percent of healthcare organizations in the European Union were employing AI technologies for disease identification, with an additional 19% intending to carry out within the next three years. Also, increasing demand to incorporate patient data and rising government initiatives for diagnosis of diabetes would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Network Point-of-Care Glucose Testing Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Network Point-of-Care Glucose Testing Device Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to of the region's rising disease prevalence. Furthermore, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing geriatric and target demographics, as well as regional growth of main market participants.

Major market players included in this report are:

  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Abbott Laboratories
  • Nipro India Corporation Pvt Ltd.
  • Nova Biomedical
  • ACON Laboratories, Inc.
  • Trividia Health, Inc.
  • Prodigy Diabetes Care, LLC
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • EKF Diagnostics

Recent Developments in the Market:

  • In October 2022, Roche launched a quick antigen diagnostic kit for detecting the COVID-19 coronavirus, with three additional configurations to be tested at home as well as by healthcare professionals.

Global Network Point-of-Care Glucose Testing Device Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered:Application, Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

by Type

  • 0.5uL
  • 1uL
  • 5uL
  • Others

By Application

  • Hospital
  • Clinic
  • Household

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Network Point-of-Care Glucose Testing Device Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Network Point-of-Care Glucose Testing Device Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Network Point-of-Care Glucose Testing Device Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Network Point-of-Care Glucose Testing Device Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Network Point-of-Care Glucose Testing Device Market Dynamics

  • 3.1. Network Point-of-Care Glucose Testing Device Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of diabetes
      • 3.1.1.2. Growing demand for medical testing kits
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Network Point-of-Care Glucose Testing Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand to incorporate patient data.
      • 3.1.3.2. Rising government initiatives for diagnosis of diabetes

Chapter 4. Global Network Point-of-Care Glucose Testing Device Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Network Point-of-Care Glucose Testing Device Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Network Point-of-Care Glucose Testing Device Market by Type, Performance - Potential Analysis
  • 5.3. Global Network Point-of-Care Glucose Testing Device Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Network Point-of-Care Glucose Testing Device Market, Sub Segment Analysis
    • 5.4.1. 0.5uL
    • 5.4.2. 1uL
    • 5.4.3. 5uL
    • 5.4.4. Others

Chapter 6. Global Network Point-of-Care Glucose Testing Device Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Network Point-of-Care Glucose Testing Device Market by Application, Performance - Potential Analysis
  • 6.3. Global Network Point-of-Care Glucose Testing Device Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Network Point-of-Care Glucose Testing Device Market, Sub Segment Analysis
    • 6.4.1. Hospital
    • 6.4.2. Clinic
    • 6.4.3. Household

Chapter 7. Global Network Point-of-Care Glucose Testing Device Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Network Point-of-Care Glucose Testing Device Market, Regional Market Snapshot
  • 7.4. North America Network Point-of-Care Glucose Testing Device Market
    • 7.4.1. U.S. Network Point-of-Care Glucose Testing Device Market
      • 7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Network Point-of-Care Glucose Testing Device Market
  • 7.5. Europe Network Point-of-Care Glucose Testing Device Market Snapshot
    • 7.5.1. U.K. Network Point-of-Care Glucose Testing Device Market
    • 7.5.2. Germany Network Point-of-Care Glucose Testing Device Market
    • 7.5.3. France Network Point-of-Care Glucose Testing Device Market
    • 7.5.4. Spain Network Point-of-Care Glucose Testing Device Market
    • 7.5.5. Italy Network Point-of-Care Glucose Testing Device Market
    • 7.5.6. Rest of Europe Network Point-of-Care Glucose Testing Device Market
  • 7.6. Asia-Pacific Network Point-of-Care Glucose Testing Device Market Snapshot
    • 7.6.1. China Network Point-of-Care Glucose Testing Device Market
    • 7.6.2. India Network Point-of-Care Glucose Testing Device Market
    • 7.6.3. Japan Network Point-of-Care Glucose Testing Device Market
    • 7.6.4. Australia Network Point-of-Care Glucose Testing Device Market
    • 7.6.5. South Korea Network Point-of-Care Glucose Testing Device Market
    • 7.6.6. Rest of Asia Pacific Network Point-of-Care Glucose Testing Device Market
  • 7.7. Latin America Network Point-of-Care Glucose Testing Device Market Snapshot
    • 7.7.1. Brazil Network Point-of-Care Glucose Testing Device Market
    • 7.7.2. Mexico Network Point-of-Care Glucose Testing Device Market
  • 7.8. Middle East & Africa Network Point-of-Care Glucose Testing Device Market
    • 7.8.1. Saudi Arabia Network Point-of-Care Glucose Testing Device Market
    • 7.8.2. South Africa Network Point-of-Care Glucose Testing Device Market
    • 7.8.3. Rest of Middle East & Africa Network Point-of-Care Glucose Testing Device Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. F. Hoffmann-La Roche AG
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Danaher Corporation
    • 8.3.3. Abbott Laboratories
    • 8.3.4. Nipro India Corporation Pvt Ltd.
    • 8.3.5. Nova Biomedical
    • 8.3.6. ACON Laboratories, Inc.
    • 8.3.7. Trividia Health, Inc.
    • 8.3.8. Prodigy Diabetes Care, LLC
    • 8.3.9. Bayer AG/Ascensia Diabetes Care Holdings AG
    • 8.3.10. EKF Diagnostics

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption